Pharmaceutical Companies

De-risk Your Trial. Accelerate Timelines.

Acclinate provides the representative data, predictive intelligence, and cultural relevance needed to meet mandates and deliver faster, more inclusive trials at scale.

Built for Pharma’s New Reality

Trust is the new enrollment driver. Representation is a requirement. Behavioral data is the differentiator. We bring all three together.

You are navigating rising regulatory scrutiny and the shift toward trust-centered engagement. Acclinate delivers the community insights and behavioral data that fuel enrollment and strengthen trial design.

Clinical Operations

Strengthen Enrollment Feasibility

Close representation gaps and accelerate timelines with predictive intelligence and trusted community pipelines across more therapeutic areas.

Commercial/Marketing

Engage Patients With Confidence

As regulatory scrutiny reshapes DTC, Acclinate enables compliant, unbranded disease education and omnichannel engagement built on cultural trust and real behavioral signals.

Patient Insights

Design Studies Around Lived Experience

Amplify patient and caregiver voices, gather real-world sentiment, and turn community insights into more inclusive protocol design and post-market understanding.

Community Partners

Build Trusted Pathways Together

Partner with local organizations to expand reach, deepen trust, and surface insights that strengthen clinical and commercial strategies.

Our Solution Stack

NOWINCLUDED

Authentic Sourcing

Exclusive access to the most trusted community in research.

e-DICT

Predictive & Regulatory Intelligence

Real-time representation, readiness, and enrollment likelihood.

Customer Success Stories

De-Risking the Pipeline

MATERNAL & FETAL HEALTH

Mobilizing Health Equity: Maternal & Fetal Health

“The U.S. has a record maternal and fetal health crisis — with Black communities experiencing disproportionately high rates of maternal and infant mortality.”
Read Case Study
164
In-depth surveys collected from moms
18,000+
Community members engaged with our materials
98
Personal stories filmed through NOWINCLUDED
FAQ

How Pharma Teams Improve Clinical Trial Diversity, Recruitment, and Trust

How does Acclinate help improve diversity in clinical trials?

Acclinate helps sponsors reach communities historically underrepresented in research through NOWINCLUDED, a trusted community platform built through culturally relevant engagement, education, and partnerships. By combining community relationships, behavioral insights, and tech enabled engagement, sponsors can identify and connect with individuals who are informed, interested, and ready to participate in research.

How is NOWINCLUDED different from traditional patient recruitment vendors?

Traditional recruitment approaches focus primarily on advertising and site referrals. NOWINCLUDED focuses on trust and sustained engagement. Our community members are engaged through health education, cultural partnerships, and ongoing dialogue long before trial recruitment begins. This approach improves awareness, readiness, and participation while reducing recruitment friction.

Can Acclinate help reduce clinical trial enrollment risk?

Yes. Enrollment delays and lack of representative participation are major risks in clinical development. Acclinate reduces these risks by providing early insights into community attitudes, barriers to participation, and engagement readiness. Sponsors can use these insights to design more effective recruitment strategies before enrollment challenges arise.

What types of insights can pharma teams gain from Acclinate’s platform?

Through Acclinate’s analytics and community engagement infrastructure, sponsors can access insights such as community health attitudes, research awareness levels, barriers to participation, cultural considerations, and behavioral engagement patterns. These insights help inform protocol design, outreach strategy, and site engagement planning.

At what stage of clinical development should sponsors engage Acclinate?

Acclinate can support sponsors across the research lifecycle, including early protocol planning, feasibility assessments, site activation support, and recruitment engagement. Engaging early in the development process allows sponsors to better understand community perspectives and build awareness before recruitment begins.

How does community engagement impact clinical trial timelines and cost?

Clinical trial delays are often driven by slow enrollment and lack of representative participation. Community engagement helps address these challenges by building awareness, trust, and research readiness before recruitment begins. When individuals already understand clinical research and trust the organizations involved, they are more likely to consider participation. This can lead to faster enrollment, improved retention, and fewer costly recruitment adjustments during a study.

Stop Risking Your Pipeline Success.

Our platform delivers the certainty and compliance your executive team requires.